{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:25:26Z","timestamp":1759623926073,"version":"build-2065373602"},"reference-count":21,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,9,30]]},"DOI":"10.1536\/ihj.25-387","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:09:06Z","timestamp":1759183746000},"page":"715-717","source":"Crossref","is-referenced-by-count":0,"title":["What Follows Prognostic Insights? Exploring the Implications of Trajectory of Left Ventricular Ejection Fraction in Cardiac Sarcoidosis"],"prefix":"10.1536","volume":"66","author":[{"given":"Takashi","family":"Hiruma","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Maeda D, Matsue Y, Fujimoto Y, <i>et al<\/i>. Association between improvement in left ventricular ejection fraction and prognosis of patients with cardiac sarcoidosis. Int Heart J 2025; 66: 786-93.","DOI":"10.1536\/ihj.25-273"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 2017; 38: 2663-70.","DOI":"10.1093\/eurheartj\/ehw328"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Grunewald J, Grutters JC, Arkema EV, Saketkoo LA, Moller DR, M\u00fcller-Quernheim J. Sarcoidosis. Nat Rev Dis Primers 2019; 5: 45.","DOI":"10.1038\/s41572-019-0096-x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. N Engl J Med 2021; 385: 1018-32.","DOI":"10.1056\/NEJMra2101555"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Lehtonen J, Uusitalo V, P\u00f6yh\u00f6nen P, M\u00e4yr\u00e4np\u00e4\u00e4 MI, Kupari M. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J 2023; 44: 1495-510.","DOI":"10.1093\/eurheartj\/ehad067"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nabeta T, Kitai T, Naruse Y, <i>et al<\/i>. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Eur Heart J 2022; 43: 3450-9.","DOI":"10.1093\/eurheartj\/ehac323"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Cheng RK, Kittleson MM, Beavers CJ, <i>et al<\/i>. Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association. Circulation 2024; 149: e1197-216.","DOI":"10.1161\/CIR.0000000000001240"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ardehali H, Howard DL, Hariri A, <i>et al<\/i>. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J 2005; 150: 459-63.","DOI":"10.1016\/j.ahj.2004.10.006"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Trivieri MG, Spagnolo P, Birnie D, <i>et al<\/i>. Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 76: 1878-901.","DOI":"10.1016\/j.jacc.2020.08.042"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Yazaki Y, Isobe M, Hiroe M, <i>et al<\/i>. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chiu CZ, Nakatani S, Zhang G, <i>et al<\/i>. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.","DOI":"10.1016\/j.amjcard.2004.08.083"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Sairaku A, Yoshida Y, Nakano Y, <i>et al<\/i>. Cardiac resynchronization therapy for patients with cardiac sarcoidosis. Europace 2017; 19: 824-30.","DOI":"10.1093\/europace\/euw223"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hiruma T, Saji M, Nanasato M, <i>et al<\/i>. Impact of Transcatheter Edge-to-Edge Repair in Patients With Cardiac Sarcoidosis: Insights From the OCEAN-Mitral Registry. J Am Heart Assoc 2025; 14: e039243.","DOI":"10.1161\/JAHA.124.039243"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fussner LA, Karlstedt E, Hodge DO, <i>et al<\/i>. Management and outcomes of cardiac sarcoidosis: a 20-year experience in two tertiary care centres. Eur J Heart Fail 2018; 20: 1713-20.","DOI":"10.1002\/ejhf.1319"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Jackson KC, Youmans QR, Wu T, <i>et al<\/i>. Heart transplantation outcomes in cardiac sarcoidosis. J Heart Lung Transplant 2022; 41: 113-22.","DOI":"10.1016\/j.healun.2021.08.012"},{"key":"16","first-page":"1305","volume":"11","year":"2014","unstructured":"16. Birnie DH, Sauer WH, Bogun F, <i>et al<\/i>. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305-23.","journal-title":"Heart Rhythm","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Terasaki F, Azuma A, Anzai T, <i>et al<\/i>. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J 2019; 83: 2329-88.","DOI":"10.1253\/circj.CJ-19-0508"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Castrichini M, Agboola KM, Vyas H, <i>et al<\/i>. Cardiac Sarcoidosis Mimickers: Genetic Testing in Undifferentiated Inflammatory Cardiomyopathies. Circ Genom Precis Med 2023; 16: 478-9.","DOI":"10.1161\/CIRCGEN.123.004099"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nishijo D, Inoue S, Dai Z, <i>et al<\/i>. Genetic cardiomyopathy mimicking isolated cardiac sarcoidosis: Diagnostic challenges with positron emission tomography. ESC Heart Fail 2025; 12: 2347-52.","DOI":"10.1002\/ehf2.15185"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Reza N, Levin MG, Vidula MK, <i>et al<\/i>. Prevalence of Pathogenic Variants in Dilated Cardiomyopathy-Associated Genes in Patients Evaluated for Cardiac Sarcoidosis. Circ Genom Precis Med 2023; 16: 409-11.","DOI":"10.1161\/CIRCGEN.122.003850"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lal M, Chen C, Newsome B, <i>et al<\/i>. Genetic Cardiomyopathy Masquerading as Cardiac Sarcoidosis. J Am Coll Cardiol 2023; 81: 100-2.","DOI":"10.1016\/j.jacc.2022.10.021"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-387\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:54:19Z","timestamp":1759550059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-387\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-387","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"article-number":"25-387"}}